View of COMPARISON OF POST-TREATMENT HBA1C LEVELS AMONG PATIENTS USING EMPAGLIFLOZIN VERSUS VILDAGLIPTIN FOR TREATMENT OF TYPE II DIABETES MELLITUS AT A TERTIARY CARE HOSPITAL.

Return to Article Details COMPARISON OF POST-TREATMENT HBA1C LEVELS AMONG PATIENTS USING EMPAGLIFLOZIN VERSUS VILDAGLIPTIN FOR TREATMENT OF TYPE II DIABETES MELLITUS AT A TERTIARY CARE HOSPITAL. Download Download PDF